Nonalcoholic steatohepatitis is the most rapidly growing indication for simultaneous liver kidney transplantation in the United States

Transplantation

Volumn 100, Issue 3, 2016, Pages 607-612

  Singal, Ashwani Kumar ^a   Hasanin, Mohsen ^b   Kaif, Mohamed ^a   Wiesner, Russell ^c   Kuo, Yong Fang ^d  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF ALABAMA   (United States)

^c MAYO CLINIC   (United States)

^d UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALCOHOL LIVER CIRRHOSIS; ARTICLE; CADAVER DONOR; CONTROLLED STUDY; FEMALE; GLOMERULUS FILTRATION RATE; GRAFT FAILURE; GRAFT SURVIVAL; HEPATITIS B; HEPATITIS C; HUMAN; KIDNEY TRANSPLANTATION; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; PRIMARY BILIARY CIRRHOSIS; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; RETRANSPLANTATION; UNITED STATES; ADVERSE EFFECTS; AGED; COMPARATIVE STUDY; EPIDEMIOLOGY; FACTUAL DATABASE; KAPLAN MEIER METHOD; KIDNEY DISEASES; MIDDLE AGED; MORTALITY; NON-ALCOHOLIC FATTY LIVER DISEASE; POSTOPERATIVE COMPLICATIONS; PROPORTIONAL HAZARDS MODEL; REOPERATION; RISK FACTOR; TIME FACTOR; TRANSPLANTATION; TREATMENT OUTCOME; TRENDS;

AGED; DATABASES, FACTUAL; FEMALE; GRAFT SURVIVAL; HUMANS; KAPLAN-MEIER ESTIMATE; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; POSTOPERATIVE COMPLICATIONS; PROPORTIONAL HAZARDS MODELS; REOPERATION; RISK FACTORS; TIME FACTORS; TISSUE AND ORGAN PROCUREMENT; TREATMENT OUTCOME; UNITED STATES;

EID: 84959922452     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0000000000000945     Document Type: Article

References (25)

1. Murray KF, Carithers RL Jr, AASLD. AASLD practice guidelines: evaluation of the patient for liver transplantation. Hepatology. 2005;41: 1407-1432.
2. Singal AK, Guturu P, Hmoud B, et al. Evolving frequency and outcomes of liver transplantation based on etiology of liver disease. Transplantation. 2013;95:755-760.
3. Gines P, Schrier RW. Renal failure in cirrhosis. N Engl J Med. 2009;361: 1279-1290.
4. Belcher JM, Garcia-Tsao G, Sanyal AJ, et al. Association of AKI with mortality and complications in hospitalized patients with cirrhosis. Hepatology. 2013;57:753-762.
5. Nair S, Verma S, Thuluvath PJ. Pretransplant renal function predicts survival in patients undergoing orthotopic liver transplantation. Hepatology. 2002;35:1179-1185.
6. Gonwa TA, McBride MA, Anderson K, et al. Continued influence of preop-erative renal function on outcome of orthotopic liver transplant (OLTX) in the US: where will MELD lead us? Am J Transplant. 2006;6:2651-2659.
7. Eason JD, Gonwa TA, Davis CL, et al. Proceedings of consensus conference on simultaneous liver kidney transplantation (SLK). Am J Transplant. 2008;8:2243-2251.
8. Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology. 2001;33:464-470.
9. Singal AK, Salameh H, Kuo YF, et al. Evolving frequency and outcomes of simultaneous liver kidney transplants based on liver disease etiology. Transplantation. 2014;98:216-221.
10. Charlton MR, Burns JM, Pedersen RA, et al. Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States. Gastroenterology. 2011;141:1249-1253.
11. Wong RJ, Aguilar M, Cheung R, et al. Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States. Gastroenterology. 2015;143:547-555.
12. Singal AK, Anand BS. Mechanisms of synergy between alcohol and hepatitis C virus. J Clin Gastroenterol. 2007;41:761-772.
13. Singal AK, Hmoud BS, Guturu P, et al. Outcome after liver transplantation for cirrhosis due to alcohol and hepatitis C: comparison to alcoholic cirrhosis and hepatitis C cirrhosis. J Clin Gastroenterol. 2013;47:727-733.
14. Wong RJ, Cheung R, Ahmed A. Nonalcoholic steatohepatitis is the most rapidly growing indication for liver transplantation in patients with hepato-cellular carcinoma in the US. Hepatology. 2014;59:2188-2195.
15. Feng S, Goodrich NP, Bragg-Gresham JL, et al. Characteristics associated with liver graft failure: the concept of a donor risk index. Am J Transplant. 2006;6:783-790.
16. Rao PS, Schaubel DE, Guidinger MK, et al. A comprehensive risk quantification score for deceased donor kidneys: the kidney donor risk index. Transplantation. 2009;88:231-236.
17. Francoz C, Nadim MK, Baron A, et al. Glomerular filtration rate equations for liver-kidney transplantation in cirrhotic patients: validation of current recommendations. Hepatology. 2014;59:1514-1521.
18. Houlihan DD, Armstrong MJ, Davidov Y, et al. Renal function in patients undergoing transplantation for nonalcoholic steatohepatitis cirrhosis: time to reconsider immunosuppression regimens? Liver Transpl. 2011; 17:1292-1298.
19. Fussner LA, Charlton MR, Heimbach JK, et al. The impact of gender and NASH on chronic kidney disease before and after liver transplantation. Liver Int. 2014;34:1259-1266.
20. Yasui K, Sumida Y, Mori Y, et al. Nonalcoholic steatohepatitis and increased risk of chronic kidney disease. Metabolism. 2011;60:735-739.
21. Targher G, Bertolini L, Rodella S, et al. Relationship between kidney function and liver histology in subjects with nonalcoholic steatohepatitis. Clin J Am Soc Nephrol. 2010;5:2166-2171.
22. Machado MV, Goncalves S, Carepa F, et al. Impaired renal function inmor-bid obese patients with nonalcoholic fatty liver disease. Liver Int. 2012;32: 241-248.
23. Park CW, Tsai NT, Wong LL. Implications of worse renal dysfunction and medical comorbidities in patients with NASH undergoing liver transplant evaluation: impact on MELD and more. Clin Transplant. 2011;25: E606-E611.
24. Sesti G, Fiorentino TV, Arturi F, et al. Association between noninvasive fibrosis markers and chronic kidney disease among adults with nonalcoholic fatty liver disease. PLoS One. 2014;9:e88569.
25. Musso G, Gambino R, Tabibian JH, et al. Associationofnon-alcoholic fatty liver disease with chronic kidney disease: a systematic review and meta-analysis. PLoS Med. 2014;11:e1001680.